Healthlead PCL (BKK:HL)

Market Cap	1.59B -16.4%
Revenue (ttm)	2.27B +12.9%
Net Income	77.86M -0.5%
EPS	0.29 +0.8%
Shares Out	256.63M
PE Ratio	21.38
Forward PE	n/a
Dividend	0.22 (3.61%)
Ex-Dividend Date	Mar 11, 2026

Volume	38,604
Average Volume	166,250
Open	6.45
Previous Close	6.10
Day's Range	6.10 - 6.45
52-Week Range	5.40 - 8.45
Beta	0.28
RSI	28.62
Earnings Date	Feb 27, 2026

About Healthlead PCL

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies and devices, as well as disinfectant and deodorizing products, masks, and sterilization products under the iCare, Pharmax, and Super Drug brands; and healthcare product innovations under PRIME, Besuto, and BOMSKIN brands. The company was incorporated in 2018 and is based in Nonthaburi,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: HL

Financial Performance

In 2025, Healthlead PCL's revenue was 2.27 billion, an increase of 12.85% compared to the previous year's 2.01 billion. Earnings were 77.86 million, a decrease of -0.52%.